Financials · AMRZ

Amrize Ltd (AMRZ) financials

For the twelve months ended Sep 30, 2026, Amrize Ltd reported $12.26B of revenue and $1.25B of net income.

Revenue, TTM
$12.26B
Revenue growth, YoY
+3.5%
Net income, TTM
$1.25B
Net income growth, YoY
+8.3%
Net margin
10.2%
Free cash flow, TTM
$1.08B
EPS, diluted, TTM
$2.27
Cash
$299.00M
Total debt
$4.94B
P/E
18.14
P/S
1.85
Market cap
$22.71B
Annual revenue$11.81B
FY2023FY2025
Annual net income$1.19B
FY2023FY2025
Annual free cash flow$1.42B
FY2023FY2025

AMRZ revenue and earnings growth

AMRZ revenueQ3 2026$3.77B

Quarter YoY
+2.2%
QoQ
+7.9%
FY YoY
+0.9%

AMRZ revenue was $3.77B in fiscal Q3 2026 (ended Sep 30, 2026), up 2.2% from a year earlier and up 7.9% from the prior quarter. For the full fiscal 2025 it was $11.81B, up 0.9% from fiscal 2024.

AMRZ net incomeQ3 2026$559.00M

Quarter YoY
+3.1%
QoQ
+16.9%
FY YoY
-7.0%

AMRZ net income was $559.00M in fiscal Q3 2026 (ended Sep 30, 2026), up 3.1% from a year earlier and up 16.9% from the prior quarter. For the full fiscal 2025 it was $1.19B, down 7.0% from fiscal 2024.

AMRZ EPSQ3 2026$1.02

Quarter YoY
+4.1%
QoQ
+18.6%
FY YoY
-7.0%

AMRZ diluted EPS was $1.02 in fiscal Q3 2026 (ended Sep 30, 2026), up 4.1% from a year earlier and up 18.6% from the prior quarter. For the full fiscal 2025 it was $2.14, down 7.0% from fiscal 2024.

AMRZ free cash flowQ3 2026$431.00M

Quarter YoY
-35.6%
QoQ
+149.1%
FY YoY
-13.4%

AMRZ free cash flow was $431.00M in fiscal Q3 2026 (ended Sep 30, 2026), down 35.6% from a year earlier and up 149.1% from the prior quarter. For the full fiscal 2025 it was $1.42B, down 13.4% from fiscal 2024.

Export CSV

Income statement

Income statement
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Revenue$11.81B$11.70B$11.68B
Cost of revenue$8.78B$8.63B$8.91B
Gross profit$3.03B$3.07B$2.77B
Selling, general and admin$1.13B$944.00M$898.00M
Operating income$1.91B$2.19B$1.89B
Interest expense$461.00M$547.00M$564.00M
Pre-tax income$1.50B$1.63B$1.30B
Income tax$326.00M$368.00M$361.00M
Net income$1.19B$1.27B$956.00M
EPS, basic$2.14$2.30$1.73
EPS, diluted$2.14$2.30$1.73
Diluted shares553.6M553.1M553.1M

Balance sheet

Balance sheet
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Cash and equivalents$1.92B$1.58B$1.11B
Inventory$1.49B$1.45B-
Current assets$4.61B$4.78B-
Goodwill$9.04B$8.92B$8.97B
Total assets$24.21B$23.80B-
Current liabilities$2.88B$2.55B-
Short-term debt$333.00M$0-
Long-term debt$4.94B--
Total debt$5.27B--
Total liabilities$11.09B$13.89B-
Shareholders' equity$13.13B$9.78B$9.20B

Cash flow

Cash flow
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Operating cash flow$2.21B$2.28B$2.04B
Capital expenditures$788.00M$642.00M$630.00M
Free cash flow$1.42B$1.64B$1.41B
Investing cash flow-$361.00M-$1.21B-$2.02B
Financing cash flow-$1.55B-$537.00M$734.00M
Stock-based compensation$14.00M$6.00M$5.00M
Depreciation and amortization$758.00M$736.00M$689.00M

Key ratios

Key ratios
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Revenue growth, YoY0.9%0.2%-
Net income growth, YoY-7.0%33.3%-
EPS growth, YoY-7.0%32.9%-
Gross margin25.7%26.2%23.7%
Operating margin16.1%18.8%16.2%
Net margin10.0%10.9%8.2%
Free cash flow margin12.0%14.0%12.0%
Return on equity9.0%13.0%10.4%
Return on assets4.9%5.4%-
Current ratio1.601.87-
Debt to equity0.40--

Source: XBRL data Amrize Ltd files with the SEC, latest filing dated Oct 29, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

AMRZ peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
AMRZ$12.26B+3.5%$1.25B10.2%$22.71B
CRH$38.96B+5.6%$3.58B9.2%$63.50B
JHX$4.84B+24.7%$104.00M2.2%$16.64B
CX$16.13B+0.4%$960.00M6.0%$16.24B
EXP$2.34B+1.6%$376.72M16.1%$5.80B
CPACPEN 2.12B+7.0%PEN 154.21M7.3%$1.08B
LOMAARS 1.51T+0.8%ARS 23.58B1.6%$1.03B
SMID$89.50M-1.6%$7.73M8.6%$134.4M

AMRZ FAQ

9 questions
  • What is AMRZ revenue?
    Amrize Ltd (AMRZ) reported $12.26B of revenue for the twelve months ended Sep 30, 2026. That is up 3.5% from the year before. Revenue for fiscal 2025 was $11.81B.
  • Is AMRZ profitable?
    Yes. Amrize Ltd earned $1.25B in net income for the twelve months ended Sep 30, 2026, a net margin of 10.2%.
  • How much cash and debt does AMRZ have?
    Amrize Ltd reported $299.00M in cash and cash equivalents and $4.94B of debt on its most recent balance sheet in SEC filings.
  • How fast is AMRZ revenue growing?
    Amrize Ltd's revenue changed +0.9% in fiscal 2025, to $11.81B.
  • What is AMRZ gross margin?
    Amrize Ltd's gross profit was $3.05B on $12.26B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 24.8%.
  • What is AMRZ free cash flow?
    Amrize Ltd generated $1.08B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $2.01B less capital expenditures.
  • What is AMRZ earnings per share?
    Diluted earnings per share were $2.27 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did AMRZ last report financial results?
    The latest statements here come from Amrize Ltd's 10-Q filed on Oct 29, 2026, covering the period ended Sep 30, 2026.
  • Where does this AMRZ financial data come from?
    Quantisnow builds these statements from the structured XBRL data Amrize Ltd files with the SEC. It is provided for information only and is not investment advice.